Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes.

Details

Ressource 1Download: ijms-17-01869.pdf (4502.20 [Ko])
State: Public
Version: Final published version
Serval ID
serval:BIB_1CD92FB671F9
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes.
Journal
International journal of molecular sciences
Author(s)
Noguchi T., Tsuchida M., Kogue Y., Spadini C., Hirata Y., Matsuzawa A.
ISSN
1422-0067 (Electronic)
ISSN-L
1422-0067
Publication state
Published
Issued date
09/04/2016
Peer-reviewed
Oui
Volume
17
Number
11
Pages
1869
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Abstract
Tumor necrosis factor receptor-associated factor 2 (TRAF2) is a critical mediator of tumor necrosis factor-α (TNF-α) signaling. However, the regulatory mechanisms of TRAF2 are not fully understood. Here we show evidence that TRAF2 requires brefeldin A-inhibited guanine nucleotide-exchange factor 1 (BIG1) to be recruited into TNF receptor 1 (TNFR1) signaling complexes. In BIG1 knockdown cells, TNF-α-induced c-Jun N-terminal kinase (JNK) activation was attenuated and the sensitivity to TNF-α-induced apoptosis was increased. Since these trends correlated well with those of TRAF2 deficient cells as previously demonstrated, we tested whether BIG1 functions as an upstream regulator of TRAF2 in TNFR1 signaling. As expected, we found that knockdown of BIG1 suppressed TNF-α-dependent ubiquitination of TRAF2 that is required for JNK activation, and impaired the recruitment of TRAF2 to the TNFR1 signaling complex (complex I). Moreover, we found that the recruitment of TRAF2 to the death-inducing signaling complex termed complex II was also impaired in BIG1 knockdown cells. These results suggest that BIG1 is a key component of the machinery that drives TRAF2 to the signaling complexes formed after TNFR1 activation. Thus, our data demonstrate a novel and unexpected function of BIG1 that regulates TNFR1 signaling by targeting TRAF2.

Keywords
Apoptosis/drug effects, Cell Line, Tumor, Gene Expression Regulation, Genes, Reporter, Guanine Nucleotide Exchange Factors/antagonists & inhibitors, Guanine Nucleotide Exchange Factors/genetics, Guanine Nucleotide Exchange Factors/metabolism, HeLa Cells, Humans, JNK Mitogen-Activated Protein Kinases/antagonists & inhibitors, JNK Mitogen-Activated Protein Kinases/genetics, JNK Mitogen-Activated Protein Kinases/metabolism, Luciferases/genetics, Luciferases/metabolism, NF-kappa B/antagonists & inhibitors, NF-kappa B/genetics, NF-kappa B/metabolism, Protein Binding, Protein Transport, Proteolysis/drug effects, RNA, Small Interfering/genetics, RNA, Small Interfering/metabolism, Receptors, Tumor Necrosis Factor, Type I/antagonists & inhibitors, Receptors, Tumor Necrosis Factor, Type I/genetics, Receptors, Tumor Necrosis Factor, Type I/metabolism, Signal Transduction/genetics, TNF Receptor-Associated Factor 2/antagonists & inhibitors, TNF Receptor-Associated Factor 2/genetics, TNF Receptor-Associated Factor 2/metabolism, Tumor Necrosis Factor-alpha/pharmacology, Ubiquitination/drug effects
Pubmed
Open Access
Yes
Create date
05/12/2016 19:43
Last modification date
20/08/2019 13:53
Usage data